What 2000+ patient groups worldwide say about pharma in 2022
May 2023: Now in its 12th year, PatientView’s Corporate Reputation of Pharma survey remains one of the few studies that explore the opinions of patient groups globally on whether pharmaceutical… Continue reading “What 2000+ patient groups worldwide say about pharma in 2022”